TPAV, LLC bought TRAW
December 29, 2024 · Form 4 insider transaction
TPAV, LLC bought 96,348 shares of Traws Pharma, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 29 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,348
Price
N/A
Total value
N/A
InsiderTPAV, LLC
Role—
CompanyTraws Pharma, Inc. (TRAW)
SecurityPre-Funded Warrant (right to buy)
Transaction codeP: Open-market purchase
Transaction dateDecember 29, 2024
Filing dateJanuary 27, 2025
Shares owned after96,348
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Pre-Funded Warrants and Series A Warrants were purchased as part of Class B Units, with each Class B Unit consisting of one Pre-Funded Warrant and one Series A Warrant, at a purchase price of $5.093 per Class B Unit.; The Pre-Funded Warrants shall become exercisable upon stockholder approval of the exercise of the Pre-Funded Warrants, in accordance with Nasdaq listing rules.; The Pre-Funded Warrants do not expire.